Elanco Animal Health Incorporat (ELAN) Stock Analysis
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $19.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak growth.
Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than 90 countries, with the U.S. accounting for 47% of total revenue. Revenue is generated through veterinary distributors, retailers and farm animal producers; the... Read more
Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $19.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak growth. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.2/10, moderate confidence.
Passes 6/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.
Recent Developments — Elanco Animal Health Incorporat
Latest news
- Analysts estimate Elanco Animal Health Incorporated (ELAN) to report a decline in earnings: What to look out for - MSN — MSN neutral
- Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for - Yahoo — Yahoo Finance negative
- Elanco Animal Health (ELAN) Receives a Buy from Bank of America Securities - The Globe and Mail — The Globe and Mail positive
- Elanco Animal Health (ELAN) to Release Quarterly Earnings on Wednesday - MarketBeat — MarketBeat neutral
- Elanco Animal Health Incorporated (ELAN) beats Q1 earnings and revenue estimates - MSN — MSN positive
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers·1 ceiling hit
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $19.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak growth. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $19.09. Score 5.2/10, moderate confidence.
Take-profit target: $25.91 (+30.0% upside). Prior stop was $19.09. Stop-loss: $19.09.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak growth; Elevated risk factors.
Elanco Animal Health Incorporat trades at a P/E of N/A (forward 16.4). TrendMatrix value score: 6.4/10. Verdict: Sell.
23 analysts cover ELAN with a consensus score of 4.3/5. Average price target: $30.
What does Elanco Animal Health Incorporat do?Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than...
Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than 90 countries, with the U.S. accounting for 47% of total revenue. Revenue is generated through veterinary distributors, retailers and farm animal producers; the top 5 product families represent approximately 38% of revenue.